Pancreatic Cancer Research

ResearcherMayo ClinicActive in the last 2 years

Luis F. Flores

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-0422-4680; OpenAlex author ID A5004007478, A5047598835. Sources: OpenAlex.

Their work

Papers
4 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: 1 paper · 2024: none · 2025: 1 paper · 2026: 1 paper

Papers 4

  1. A Novel Emerin/Nesprin-3 Interaction Mediates Nuclear Size Changes Induced by Oncogenic KRAS in Pancreatic Cancer Cells. First author DOI 10.1080/10985549.2026.2670710↗
  2. Emerin is an effector of oncogenic KRAS-driven nuclear dynamics in pancreatic cancer. Co-author DOI 10.1172/jci.insight.187799↗
  3. GLI1 interaction with p300 modulates SDF1 expression in cancer-associated fibroblasts to promote pancreatic cancer cells migration. Co-author DOI 10.1042/bcj20220521↗
  4. Nuclear Dynamics and Chromatin Structure: Implications for Pancreatic Cancer. Co-author DOI 10.3390/cells10102624↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Martín E. Fernández-Zapico · 4 shared papers, 2021–2026 · strength 0.79
  2. Renzo Emanuel Vera · 3 shared papers, 2023–2026 · strength 0.63
  3. Brooke R Tader · 3 shared papers, 2021–2026 · strength 0.62
  4. Ezequiel J. Tolosa · 3 shared papers, 2021–2025 · strength 0.52
  5. Kayla C. LaRue-Nolan · 2 shared papers, 2025–2026 · strength 0.46
  6. Aleksey V. Matveyenko · 1 shared paper, 2025 · strength 0.19
  7. Catherine E. Hagen · 1 shared paper, 2025 · strength 0.19
  8. Rondell Patrell Graham · 1 shared paper, 2025 · strength 0.19
  9. David R Pease · 1 shared paper, 2025 · strength 0.19
  10. Ryan Michael Carr · 1 shared paper, 2025 · strength 0.19
  11. Christopher L. Pin · 1 shared paper, 2025 · strength 0.19
  12. David W. Dawson · 1 shared paper, 2025 · strength 0.19

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.